Companies/Aoxing Pharmaceutical Company, Inc.

Company profile

Aoxing Pharmaceutical Company, Inc.

OTC: AOXG · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Foster City, CIK 0001060426Reports USD

#489 of 1,402 Healthcare companies by revenue70th-percentile growth

EA Score

——

FH —DQ —GM —SS 60

v0.1 · 5/100 weight · pillars only

↑ operating margin, return on assets · ↓ market scale, disclosure history

Methodology →

Revenue TTM

$32.3M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

$2.1M

Employees

346

Market cap

$266.8k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$32.3M$32.3M2016

Net income$2.1M$2.1M2016

Operating income$6.2M$6.2M2016

Total assets$56.2M$56.2M2016

Equity$19.1M$19.1M2016

Revenue trend

FY2012 – FY2016 · USD

$6.7M

FY12

$8.1M

FY12

$10.8M

FY13

$12.7M

FY14

$25.5M

FY15

$32.3M

FY16

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Aoxing Pharmaceutical Company, Inc. booked $32.3M in FY2016 revenue, growing 27% year over year — faster than most Healthcare companies we track, at a 6.4% net margin.

Peers · Healthcare

Apptly Health Technologies Corp.——Marijuana Inc.——FutureWorld Corp.——GlucoTrack, Inc.26D

Key facts

CEOZhenjiang Yue

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersFoster City, null

ExchangeOTC: AOXG

Employees346

IPO date2005-02-21

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.